RGD peptide-pegylated PLLA nanoparticles containing epirubicin hydrochloride exhibit receptor-dependent tumor trafficking in vitro and in vivo
- Type
- Retraction
- Notice date
- 2/2/2016 0:00
- Journal
- Pharmaceutical Research
- Publisher
- Springer
- Notice DOI
- 10.1007/s11095-016-1866-8
- Original paper DOI
- 10.1007/s11095-015-1625-2